Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotatercept for bone mass in multiple myeloma
NCT02230917Phase 2Withdrawn
- Start
- Oct 2014
- Primary completion
- Apr 2016
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of sotatercept in multiple myeloma (MM). Planned start Oct 2014; status: withdrawn.
02
Drugs
sotatercept
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02230917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02230917.